William D. Waddill, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 6,628 shares at $64.23 ($430K) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Seasonal sale ($430k) by Director — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.23 | 2,100 | $135K | 31.4% |
| 2 | $65.01 | 2,128 | $138K | 32.2% |
| 3 | $65.01 | 2,128 | $138K | 32.2% |
| 4 | $66.25 | 272 | $18K | 4.2% |
| Total | $64.81 avg | 6,628 | $430K | 100% |
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |